Stocklytics score rationale: value 56, quality 67, growth 42.
Financials
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
27889000000
30186000000
30821000000
33754000000
24354000000
24696000000
29324000000
30328000000
31376000000
32667000000
GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines…
Forecast
Consensus Hold from 9 analysts. Average price target $60.00, +24.0% versus the current price. Low $60.00. High $60.00.
Analysts have an average 12-month price target of $60.00 for GSK (GSK), 23.9% above the current price of $48.44. Of 9 analysts covering the stock, 4 rate it Buy or Strong Buy, 4 Hold, and 1 Sell or Strong Sell, giving a consensus of Hold.
Forecasts are third-party estimates and often wrong. They are not investment advice.
GSK price target
12-month price target
Low
$60.00
Average
$60.00
High
$60.00
The average is 23.9% above the current price of $48.44.
Is GSK a buy or sell?
Of 9 analysts, 4 rate GSK Buy or Strong Buy, 4 Hold, and 1 Sell or Strong Sell. The consensus label is Hold. That split is not a recommendation.
The Stocklytics Score for GSK is 55 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
GSK forecast FAQs
What is the GSK price target?
$60.00 average, with a published range of $60.00 to $60.00.
Is GSK a buy or sell?
The consensus is Hold from 9 analysts. This is not a recommendation.
What is the GSK stock forecast for 2026?
Analysts' average EPS estimate for 2026 on file is $3.62. The average revenue estimate is $34.20 billion.
What will GSK be worth in 2030?
No reliable forecast exists that far out.
When is GSK's next earnings report?
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.